Here, the study demonstrates the ability of TOI-based DTI to map the disease-related stages of ALS in vivo so that MRI has a differential part than fluid markers like neurofilament light chain which correlates with disease progression rate and is negatively associated with survival, thus providing prognostic information [27]. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.